BAAM
BNTX icon

Baker Avenue Asset Management’s BioNTech BNTX Stock Holding History

Baker Avenue Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2
Closed -$249 – 1597
2023
Q1 		$249 Buy
+2
New +$275 ﹤0.01% 1590

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baker Avenue Asset Management's BNTX Position: Q2 2023 in Review

Baker Avenue Asset Management sold out of BioNTech (BNTX) in Q2 2023, closing a stake of 2 shares — an estimated $249 sold.

Baker Avenue Asset Management first reported a position in BNTX in Q1 2023 and held it in 1 quarter. The position peaked at $249 in Q1 2023. 253 funds tracked by Wall St. Rank hold BNTX as of Q2 2023.

  • Baker Avenue Asset Management reported no remaining BioNTech position as of Q2 2023 after selling out during the quarter.
  • Baker Avenue Asset Management sold 2 BioNTech shares in Q2 2023, an estimated $249.
  • Baker Avenue Asset Management first reported a position in BioNTech in Q1 2023 and held it in 1 quarter.
  • Baker Avenue Asset Management's BioNTech position peaked at $249 in Q1 2023.
  • 253 funds tracked by Wall St. Rank held BioNTech as of Q2 2023.

Based on Baker Avenue Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.